These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15990182)

  • 1. Comparison of antagonist activity of spantide family at human neurokinin receptors measured by aequorin luminescence-based functional calcium assay.
    Janecka A; Poels J; Fichna J; Studzian K; Vanden Broeck J
    Regul Pept; 2005 Nov; 131(1-3):23-8. PubMed ID: 15990182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant aequorin as a reporter for receptor-mediated changes of intracellular Ca2+ -levels in Drosophila S2 cells.
    Torfs H; Poels J; Detheux M; Dupriez V; Van Loy T; Vercammen L; Vassart G; Parmentier M; Vanden Broeck J
    Invert Neurosci; 2002 Apr; 4(3):119-24. PubMed ID: 12488971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the cloned human NK3 receptor in Chinese Hamster Ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer.
    Jordan RE; Smart D; Grimson P; Suman-Chauhan N; McKnight AT
    Br J Pharmacol; 1998 Oct; 125(4):761-6. PubMed ID: 9831912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
    Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
    Lecci A; Capriati A; Altamura M; Maggi CA
    Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurokinin receptor modulation of respiratory activity in the rabbit.
    Bongianni F; Mutolo D; Cinelli E; Pantaleo T
    Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neurokinins on canine prostate cell physiology.
    Walden PD; Marinese D; Srinivasan D; Tzoumaka E; Syyong HT; Ford AP; Bhattacharya A
    Prostate; 2005 Jun; 63(4):358-68. PubMed ID: 15611996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of tachykinin-related peptides from different insect species on Drosophila tachykinin receptor-expressing cell line.
    Fichna J; Poels J; Broeck JV; Janecka A
    Chem Biol Drug Des; 2006 Nov; 68(5):284-6. PubMed ID: 17177889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain.
    Rigby M; O'Donnell R; Rupniak NM
    J Comp Neurol; 2005 Oct; 490(4):335-53. PubMed ID: 16127708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachykinin receptor expression and function in human esophageal smooth muscle.
    Kovac JR; Chrones T; Preiksaitis HG; Sims SM
    J Pharmacol Exp Ther; 2006 Aug; 318(2):513-20. PubMed ID: 16714401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological assessment of spantide II analogues.
    Wang ZY; Feng DM; Wang YL; Tung SR; Wong K; Strichartz GR; Folkers K; Håkanson R
    Eur J Pharmacol; 1994 Aug; 260(2-3):121-8. PubMed ID: 7527343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence for neurokinin receptors in murine neuroblastoma C1300 cells.
    Fukuhara S; Mukai H; Munekata E
    Peptides; 1995; 16(2):211-4. PubMed ID: 7540290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for tachykinins in female mouse and rat reproductive function.
    Pintado CO; Pinto FM; Pennefather JN; Hidalgo A; Baamonde A; Sanchez T; Candenas ML
    Biol Reprod; 2003 Sep; 69(3):940-6. PubMed ID: 12773411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of the human neurokinin receptors NK1, NK2, and NK3 based on a cellular assay system.
    Stratowa C; Machat H; Burger E; Himmler A; Schafer R; Spevak W; Weyer U; Wiche-Castanon M; Czernilofsky AP
    J Recept Signal Transduct Res; 1995; 15(1-4):617-30. PubMed ID: 8903968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [D-1-Nal4]endomorphin-2 is a potent micro-opioid receptor antagonist in the aequorin luminescence-based calcium assay.
    Fichna J; Piestrzeniewicz M; Gach K; Poels J; Burgeon E; Vanden Broeck J; Janecka A
    Life Sci; 2006 Aug; 79(11):1094-9. PubMed ID: 16624333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachykinin activation of human monocytes from patients with rheumatoid arthritis: in vitro and ex-vivo effects of cyclosporin A.
    Lavagno L; Bordin G; Colangelo D; Viano I; Brunelleschi S
    Neuropeptides; 2001 Apr; 35(2):92-9. PubMed ID: 11384204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism.
    Salthun-Lassalle B; Traver S; Hirsch EC; Michel PP
    Mol Pharmacol; 2005 Nov; 68(5):1214-24. PubMed ID: 16077032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.